We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Now I feel bad.
I've got my fingers crossed hoping DEV goes down.
Hants, I don`t care now, I doubled my money here and put my money where my opinion is yesterday, so to speak, when I sold out 100% as the sell off began.
Yes there is resistance at 270p, which is being challenged, but I decided to add to my Dev Clever position with the funds, at 31.5p, because I see a much higher, faster gain there in the short/medium term....target 50p, so about 60% if my timing is right. For a 60% rise here the sp would have to reach 400p, so the move was a no brainer for me.
Have a look at the chart over there, bouncing off the rising trend line, right on the rising 50 day ema, and daily stochastics oversold and x`ing to the upside.
The risk/reward set up was too attractive to miss.
By the way, Dev closed at 34p yesterday, so a good 5% start towards my target in half a day!
An easy trading decision.
I guarantee Simon James is is deep under water on Novacyt. Was probably buying all the way up to £12 and continued buying all the way back down to £7.
Then buying “the dips” again at 4.40 not realising it’s no longer a dip when it’s the actual SP.
He can’t stand the fact that a company with huge commercial potential and potentially life changing IP is worth more than a 1 trick pony he will never get his money back.
SimonJames...
Do i have to book well in advance for my haircut?
And by the way, dude, it is "Doctor" Alastair Smith to you!
SimonJames,
Excuse me sir, you seem well versed in making shares analysis after post presentations and took your time to write here in the board of AVACTA to let us know your thoughts, yet, this was your second post in the LSE boards?
You are telling us, you opened an account with the LSE just to write this to us?
You seem like the king of guy who deal with shares longer than this and you never posted about other shares? And by the way, you certainly don't have share here, so why bother giving us your thoughts?
You are the most obvious farse of a poster I have ever seen!!
Jog on dude!
ST
Well Simon you’ve proved me wrong, I thought GBK was the biggest K nob to post on here.
YAWN
Thanks for popping in with your expert analysis Simon,
At least your no longer recommending strong sell........ Cheerio
Yep, GAD made the CV batches
Do we know who made the batch for the CV batches?
I’ll give you that jdt, of course. It’s quite what I meant though. Just thought the presentation, even though it was delivered very well, sounded a tiny bit replay in parts.
Still in huge awe of the Company, the tech and the opportunity and thrilled to be involved. I’ve probably been unrealistic and expecting a bit too much too soon and all at the same time.
Rollyroll, if it makes you feel better the charts and tea leaves suggest that selling now and hoping for a pull back would not be a good move. We're in an ascending triangle pattern which should complete over the coming few sessions.
If we drop out the pattern that's not good, but I can't see there's much motivation to sell out at this point. The profit taking seems to have already happened from those who want to move on. So basically, a break to the downside doesn't seem likely unless we get some unexpected bad news.
We need to break above 272 ish, and we need close above that level at the end of the days trading. The traders will be in for their 10%, which should push us onwards to about 300p. There might be a slight pullback with profit taking, but even with a notable pull back 272 ish should be our new support level, where currently it is resistance.
If nothing bad happens, it's going onwards to around 300p on good news or technicals.
Bottomzup, do you think the same?
Please note: If anything happens, all of the above will go out the window as news overides charts. But in the absence of anything notable happening, that's how it should play out. Especially as the anticipation builds.
Tbf urbansea they had less than an hour (plus 10 mins of what turned out to be dog sh*t question time) to try and run through everything Avct had going on at the moment. Nye on impossible I would say unless AS spoke at 1000mph. Bear in mind also, what they are talking about isnt biscuit packing it’s cutting edge science being explained to Joe Bloggs, needs time.
Think there was a conscious effort to give the mob what they wanted i.e. the “where’s my test brigade” but also showcase the long term future of the business to LTHs with therapeutics stuff. Not much room for anything else in any detail.
Real shame the Qs covered everything spoken about in the prezzo. I know they sometimes post written responses to the Qs they couldn’t fit in (where possible) a while after the prezzo.
Maybe some of the stuff you thought was missing will get an answer. I specifically asked about progress on the neutralising therapy.
Spot on carlotowl - the therapeutics will make a very welcome change from LFT chat.
The slide today where it stated the $56bn chemo market was limited due to the fact human body could only tolerate a limited amount of the drug.
Just imagine if Avct could reduce the toxicity to the body, prove it up in clinical human trials, allowing more dosage. Of course the big win there is the fact this would help many fight a horrendous disease.
BUT that $56bn industry would get a hell of a lot bigger and Avct would blow the door right open of the current competitors.
It’s disruptive tech in the pharma world and I love it.
PL, I think my reality is that I thought, although subconsciously, that AS et all were superheroes and I’m now beginning to realise they’re not quite superheroes but still v good.
I’m much less deflated than at the end of last week, following the prolonged and bad mannered silence. Since then and today I’m much more on board with a normal bunch of non superheroes who are de-briefing us fairly well.
I think the tech is def superhuman though and is hopefully in the right hands. Time will tell if it should be in their hands or perhaps in others. Still cool, for now and confident we’ll make bundles, one way or tother.
One of the best things about Avacta is this great board. They should read it more often. Hi all ;)
I'd be very surprised if we have 3 weeks dead time now.
I think this next 2 weeks will be news rich. I'm guessing he'll RNS the SA variant revelation as they RNS'd the others. Then he's saying "very" early May for CE Mark Then commercialisation.
Can't start selling In May with some sort of volume behind them, he's already said GAD have produced a commercial batch so I think we'll hear about our other manufacturers.
We might even hear about the parallel home use CE or the US manufactures, or the overseas Manufacturers.
Can't see it being dead myself, but who knows....
Livedataaccount...today has been about giving iis the heads up and they will be buying in...unfortunately they will hard ball their order price so good chance we'll see this dip. The next couple of RNSs will support their buy in and they will want to be in when the Govt contract is announced early May...then this will rip and all our angst will be history...
Today was for it's not pi's...
There really isn't much more to discuss here. The affimer platform is completely derisked. The LFT WILL bring in enough revenue to fund the company going forward. News on manufacturers, licensing, UK (or other national Gov) contracts, takeover interest, NASDAQ listing, or any number of left field deals could literally land any day. If you don't need the money you have invested here right now then just sit tight. The derampers are scraping the barrell now and it's pretty pathetic. Can we start talking about therapeutics now because that's much more exciting!
Surplus tests to sovereign use I understood will be available for us to brand label using the capacity not required which leads me to think AffiDX was picked by HMG. Without the early results from Wetherby last year and the desire to beat covid being an imperative the government push to build a consortium of manufacturers would never have happened. AVCT has had to become a test proprietor to fulfil a consortium produced sovereign test so the government can produce the correct documents if you like. This is what the achievement has been; becoming a test developer and outsourcing manufacturer from a position of just being an affimer reagent/affimer licencing company in just over a year. It has been a tough year for AS and the Government but I think it won't be long now.
Totally agree on the in. I’ve said more than enough that the HMG connection is important for so many reasons. None more so than accessing their (now know) monopolised manufacturing capacity :)
I really like how AS hasn’t picked a side with HMG though. He’s kept them as one of many clients. I’m impressed if that’s by design. Other companies/manufacturers are in bed with HMG and that can sting both your pocket and reputation.
Manufacture as much as we can, then work down the list of customers.
I think. The share price hasn't risen as Avacta haven't got ant confirmed orders, or a CE mark.
Once that's comes the SP should rise. But, Avscta have a history if slippage on timescales. You would hope CE mark is a formality.
Then, as for sales, it depends how many they can manufacture and when? Sometime in May?
I want to bed-and-ISA what isn't already in my ISA. The transfer will probably happen over a night at minimum as a £1 test took 24hrs with HL.
On the one hand this afternoon would have been a good time to sell – after the presentation and with a little while before CE etc – and then buy back tomorrow morning. But who's to guarantee 100% there won't be more news in the morning...
I've missed my chance for today. Could there be anything on Monday?
We will exit higher NDN. Even at the 5m capacity in May we’ll break 350p. So in 7 months, that’s a great return in my book. Appreciate others have different investment/trading strategies.
Yes, the 5m capacity is all but priced in, but it’ll bring bigger money as the future capacity will only increase.
Let’s face it. There’ll be nerves in the market until Avacta get a test to market. The saliva switch still haunts.
Lol more loyal than Jose.
Oh im sure Avacta will be a lot higher in 2 months time. Just would rather have trimmed at 270, now have to deal with margin calls as the MM bring it down for a few weeks.
Staying loyal? It's Avacta PLC, not AVACTA FC, Rolly.